SELLAS Life Sciences Group, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €9.76M
    R&D expenses
    €13.70M
    EBITDA
    -€23.23M
    D&A
    -€8.32M
    EBIT
    -€23.46M
    Interest expenses
    €0.00
    EBT
    -€22.66M
    Tax expenses
    €8.32M
    Net income
    -€22.66M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€815.57K
    Changes in working capital
    -€1.86M
    Operating cash flow
    -€27.06M
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €36.77M
    Debt repayment
    €0.00
    Other financing cash flow
    €4.25M
    Net financing cash flow
    €41.00M
    Foreign exchange effects
    €0.00
    Net change in cash
    €13.94M
    Cash at end of period
    €21.92M
    Free cash flow
    -€27.06M

    Balance sheet

    Cash and cash equivalents
    €21.92M
    Cash and short-term investments
    €21.92M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €3.50M
    Total current assets
    €25.41M
    Property, plant & equipment
    €589.45K
    Goodwill
    €1.65M
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €225.25K
    Total non-current assets
    €2.47M
    Total assets
    €27.88M
    Accounts payable
    €2.88M
    Short-term debt
    €500.56K
    Other current liabilities
    €1.80M
    Total current liabilities
    €5.18M
    Long-term debt
    €135.50K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €135.50K
    Total liabilities
    €5.31M
    Common stock
    €8.63K
    Retained earnings
    -€224.85M
    Other equity
    €0.00
    Total equity
    €22.57M
    Total liabilities and shareholders' equity
    €27.88M

    Company information

    Market capitalization
    €165.96M
    Employees
    15
    Enterprise Value
    €121.06M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -100.4% Even with peer group: -95.6%
    ROA
    -81.3% Better than peer group: -92.4%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -16.3%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.51M

    Notifications